New CAR T-cell therapy offers hope for children with aggressive blood cancer
HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell.
Drugs
Health
Medical
Drugs
Health
Pharma
Merck’s trial drug combination for colorectal cancer fails main goal
Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of.
Drugs
Health
Pharma
Merck’s advanced lung cancer drug gets US drug regulator’s nod
Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug.
Drugs
Health
Medical
World’s first lung cancer vaccine given to patient in UK as human trials begin
HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known.
Drugs
Health
Pharma
Citius’s blood cancer drug gets US regulatory body’s clearance
Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.
Drugs
Health
Pharma
Merck halts small cell lung cancer immunotherapy drug trial
Merck has stopped an end-stage combination immunotherapy trial for a lung cancer condition, following recommendations of an independent data monitoring committee, which indicated.
Drugs
Health
Pharma
NIH researchers make AI tool to read cancer responses to immunotherapy
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer.
Drugs
Medical
Pharma
Merck’s Keytruda receives FDA nod for cervical cancer treatment
HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.
Drugs
Health
Pharma
ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
Drugs
Health
Pharma
Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.